Pages that link to "Q28115840"
Jump to navigation
Jump to search
The following pages link to The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers (Q28115840):
Displaying 50 items.
- Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study (Q24618920) (← links)
- Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis (Q24632905) (← links)
- Recent advances in the molecular understanding of glioblastoma (Q24632928) (← links)
- Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools (Q24632950) (← links)
- Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T (Q24646348) (← links)
- NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age (Q26830388) (← links)
- Protein tyrosine phosphatases as wardens of STAT signaling (Q26861574) (← links)
- Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer (Q27853197) (← links)
- Focal DNA copy number changes in neuroblastoma target MYCN regulated genes (Q28115604) (← links)
- Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity (Q28118996) (← links)
- Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis (Q28584911) (← links)
- Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands (Q33722795) (← links)
- Genomics of squamous cell lung cancer (Q33777454) (← links)
- Evaluation of microsatellite variation in the 1000 Genomes Project pilot studies is indicative of the quality and utility of the raw data and alignments (Q33790698) (← links)
- Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome (Q33840816) (← links)
- Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing (Q33917547) (← links)
- Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? (Q33921803) (← links)
- Integration and analysis of genome-scale data from gliomas. (Q33950522) (← links)
- Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease (Q33990951) (← links)
- Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint Hypothesis (Q34025926) (← links)
- A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. (Q34065944) (← links)
- STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma. (Q34154674) (← links)
- Inside the human cancer tyrosine phosphatome (Q34156227) (← links)
- Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. (Q34186632) (← links)
- Identification and functional analysis of 9p24 amplified genes in human breast cancer (Q34191958) (← links)
- Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. (Q34308099) (← links)
- Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis (Q34334463) (← links)
- Genetic determinants at the interface of cancer and neurodegenerative disease (Q34422582) (← links)
- Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes (Q34536679) (← links)
- Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma (Q34550261) (← links)
- Tailoring tyrosine kinase inhibitors to fit the lung cancer genome. (Q34754045) (← links)
- Genetic alterations and signaling pathways in the evolution of gliomas (Q35001574) (← links)
- Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity (Q35032621) (← links)
- Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors (Q35224188) (← links)
- Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma (Q35382936) (← links)
- Cross-talk between phospho-STAT3 and PLCγ1 plays a critical role in colorectal tumorigenesis (Q35386200) (← links)
- Losing balance: Hardy-Weinberg disequilibrium as a marker for recurrent loss-of-heterozygosity in cancer (Q35565689) (← links)
- Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma (Q35606411) (← links)
- Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival (Q35738663) (← links)
- Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility (Q35915024) (← links)
- Targeting the interleukin-6/Jak/stat pathway in human malignancies (Q35925127) (← links)
- Studying a complex tumor: potential and pitfalls (Q35929525) (← links)
- Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. (Q35934571) (← links)
- PTPRD silencing by DNA hypermethylation decreases insulin receptor signaling and leads to type 2 diabetes (Q35955186) (← links)
- Delving into somatic variation in sporadic melanoma (Q36030770) (← links)
- Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene. (Q36092374) (← links)
- Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization. (Q36097570) (← links)
- Receptor protein tyrosine phosphatases and cancer: new insights from structural biology (Q36338678) (← links)
- A Joint Bayesian Model for Integrating Microarray and RNA Sequencing Transcriptomic Data (Q36379915) (← links)
- Increased metastasis with loss of E2F2 in Myc-driven tumors (Q36545999) (← links)